Nasdaq-100 addition for Moderna can alter passive biotech flows
Question
Nasdaq-100 addition for Moderna can alter passive biotech flows
Direct answer
Nasdaq-100 inclusion can create benchmark demand for MRNA and alter passive flows in QQQ-related products.
- Original publisher
- Market Ontology
- Evidence through
- 2026-10-19
- Published
- 2026-10-20
- Revision
- 1 · 2026-10-20
Cite as: Market Ontology, “Nasdaq-100 addition for Moderna can alter passive biotech flows”, revision 1, evidence through 2026-10-19. https://marketontology.com/market-events/2026-10-19/nasdaq-100-addition-for-moderna-can-alter-passive-biotech-flows-f56c5d
What happened next
| Asset | Call | Base close | +1 day | +5 days | +20 days |
|---|---|---|---|---|---|
| QQQ | Mixed | 728.95 2026-10-14 | Pending | Pending | Pending |
Closing prices from stored daily bars; returns measured from the last close on or before the event date. Not a recommendation.
No verifiable public source recorded for this card.
Related
- 2026-10-19Moderna joins the Nasdaq-100 and may lift passive demandMRNA QQQ
- 2026-10-19Moderna joins Nasdaq-100 after 700% stock surgeMRNA QQQ
- 2026-10-19Moderna joins the Nasdaq-100 and may lift passive demandMRNA QQQ
- 2026-10-19Moderna joins the Nasdaq-100 after a 700% stock surgeMRNA QQQ
- 2026-10-19Warsh comments point to more accommodation, then higher rates laterDGS10 QQQ
- 2026-10-19Moderna joins the Nasdaq-100 after a sharp stock surgeMRNA QQQ
- 2026-10-19Moderna Joins Nasdaq-100 Following 700% YTD Rally on COVID, Flu, and Cancer Trial ResultsMRNA QQQ
- 2026-10-19Moderna Added to Nasdaq-100 Index Following Share SurgeMRNA QQQ
See today's live cards
Public pages are published 24 hours after the product shows them. Desk shows every catalyst, event and causal reading as it happens, mapped to your holdings.